{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:51:04Z","timestamp":1753876264262,"version":"3.41.2"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Prosthetic valve thrombosis (PVT) is a severe complication of mechanical valve replacement. Simultaneous thrombosis of multiple prosthetic valves is rare and is associated with worse outcomes. Treatment options include anticoagulation, thrombolysis, and redo operative valve replacement, with rare reports of adjunctive balloon valvuloplasty. There is limited evidence to guide therapeutic selection, specifically dosing, timing, and duration of thrombolysis. The following case series highlights the importance of successful thrombolytic management in dual PVT with high bleeding risk defined as a coagulopathy with an elevated international normalized ratio greater than 3 and New York Heart Association (NYHA) Class III and IV heart failure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>We describe two patients with concomitant aortic and mitral PVT. Both patients presented in NYHA Class III and IV heart failure with different challenges to surgical treatments including high bleeding risk from coagulopathy and history of multiple prior sternotomies. After multi-disciplinary discussions, both patients underwent a combination of low-dose, slow, or ultra-slow infusion of tissue plasminogen activator, with a resolution of their dual PVT seen on cine-fluoroscopy imaging as freely moving mechanical leaflets and improvement of heart failure symptoms back to baseline NYHA Class II or lower.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Prosthetic valve thrombosis is a complex medical condition requiring a multi-disciplinary team to evaluate the best course of treatment. A trial of pharmacologic thrombolysis is often the first attempted treatment for obstructive PVT, although surgery is recommended for patients with NYHA IV symptoms, or with contraindications to thrombolysis, including high bleeding risk. However, in patients with high bleeding risk and NYHA Class III and IV heart failure, especially with surgical contraindications, low-dose thrombolytics, with slow or ultra-slow infusions, may still be safe and effective treatment strategies for multi-valve PVT. Further research is needed to guide thrombolysis in multi-valve PVT.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytad399","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T05:24:31Z","timestamp":1692422671000},"source":"Crossref","is-referenced-by-count":0,"title":["Dual mechanical valve thrombosis resolution through thrombolytics: a case series"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6942-7665","authenticated-orcid":false,"given":"Colin","family":"McGuire","sequence":"first","affiliation":[{"name":"Department of Medicine, Georgetown University Hospital , Washington, DC , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Medstar Washington Hospital Center , 110 Irving St., NW, Washington, DC , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Papolos","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Medstar Washington Hospital Center , 110 Irving St., NW, Washington, DC , USA"},{"name":"Department of Critical Care Medicine, Medstar Washington Hospital Center , 110 Irving St., NW, Washington, DC , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby","family":"Rogers","sequence":"additional","affiliation":[{"name":"Section of Interventional Cardiology, MedStar Washington Hospital Center , Washington, DC , USA"},{"name":"Cardiovascular Intervention Program, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, MD , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0146-9535","authenticated-orcid":false,"given":"Benjamin","family":"Kenigsberg","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Medstar Washington Hospital Center , 110 Irving St., NW, Washington, DC , USA"},{"name":"Department of Critical Care Medicine, Medstar Washington Hospital Center , 110 Irving St., NW, Washington, DC , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,8,19]]},"reference":[{"key":"2023092917434022100_ytad399-B1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/CRD.0b013e3182638578","article-title":"Antithrombotic therapy in patients with heart valve prostheses","volume":"21","author":"Hermans","year":"2013","journal-title":"Cardiol Rev"},{"key":"2023092917434022100_ytad399-B2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/hrt.2005.071183","article-title":"Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations","volume":"93","author":"Roudaut","year":"2007","journal-title":"Heart"},{"key":"2023092917434022100_ytad399-B3","first-page":"e8760","article-title":"Clinical outcomes of mechanical prosthetic valve thrombosis","volume":"12","author":"Sharif Khan","year":"2020","journal-title":"Cureus"},{"key":"2023092917434022100_ytad399-B4","doi-asserted-by":"crossref","first-page":"932","DOI":"10.14740\/jocmr2392w","article-title":"Treatment of prosthetic valve thrombosis: current evidence and future directions","volume":"7","author":"Biteker","year":"2015","journal-title":"J Clin Med Res"},{"key":"2023092917434022100_ytad399-B5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12055-020-01041-9","article-title":"Mechanical prosthetic valve thrombosis in current era: 5-year follow-up","volume":"37","author":"Mahindru","year":"2021","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"2023092917434022100_ytad399-B6","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jtcvs.2003.12.013","article-title":"Prosthetic valve thrombosis: twenty-year experience at the Montreal heart institute","volume":"127","author":"D\u00fcrrleman","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2023092917434022100_ytad399-B7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ahj.2015.04.025","article-title":"Ultraslow thrombolytic therapy: a novel strategy in the management of PROsthetic MEchanical valve thrombosis and the prEdictors of outcomE: the ultra-slow PROMETEE trial","volume":"170","author":"\u00d6zkan","year":"2015","journal-title":"Am Heart J"},{"key":"2023092917434022100_ytad399-B8","first-page":"977","article-title":"Thrombolysis or surgery in patients with obstructive mechanical valve thrombosis: the multicenter HATTUSHA study","volume":"79","author":"Mehmet \u00d6zkan","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023092917434022100_ytad399-B9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.acvd.2009.01.007","article-title":"Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases","volume":"102","author":"Roudaut","year":"2009","journal-title":"Arch Cardiovasc Dis"},{"key":"2023092917434022100_ytad399-B10","first-page":"268","article-title":"Predictors of the outcome of thrombolytic therapy in prosthetic mitral valve thrombosis: a study of 62 events","volume":"18","author":"Nagy","year":"2009","journal-title":"J Heart Valve Dis"},{"key":"2023092917434022100_ytad399-B11","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jacc.2013.07.075","article-title":"Treatment of obstructive thrombosed prosthetic heart valve","volume":"62","author":"Huang","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023092917434022100_ytad399-B12","first-page":"980","article-title":"A global perspective on mechanical prosthetic heart valve thrombosis: diagnostic and therapeutic challenges","volume":"16","author":"G\u00fcrsoy","year":"2016","journal-title":"Anatol J Cardiol"},{"key":"2023092917434022100_ytad399-B13","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"2023092917434022100_ytad399-B14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"2023092917434022100_ytad399-B15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcmg.2012.10.016","article-title":"Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial","volume":"6","author":"\u00d6zkan","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023092917434022100_ytad399-B16","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1177\/2048872619846329","article-title":"Fibrinolysis in left-sided mechanical prosthetic valve thrombosis with high INR","volume":"9","author":"Nishanth","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2023092917434022100_ytad399-B17","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/jocs.14777","article-title":"Safety of thrombolytic therapy in patients with prosthetic heart valve thrombosis who have high international normalized ratio levels","volume":"35","author":"Farzaneh","year":"2020","journal-title":"J Card Surg"},{"key":"2023092917434022100_ytad399-B18","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"2023092917434022100_ytad399-B19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/ehjci\/jew025","article-title":"Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging","volume":"17","author":"Lancellotti","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytad399\/51172882\/ytad399.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/9\/ytad399\/51388132\/ytad399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/9\/ytad399\/51388132\/ytad399.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T17:44:32Z","timestamp":1696009472000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytad399\/7246088"}},"subtitle":[],"editor":[{"given":"Rita","family":"Pavasini","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Faten","family":"Yahia","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Massimo","family":"Mapelli","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"John","family":"Kanakakis","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Piotr Nikodem","family":"Rudz\u00ednski","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Ali Nazmi","family":"Calik","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Marta","family":"Pavarelli","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,19]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytad399","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,8,19]]},"article-number":"ytad399"}}